Thus, upregulation of miR-132-3p, miR-892a, miR-142-3p, miR-142-5p and miR-200a-3p associated with silenced activity of CYP1A1 can have therapeutic potential in Alzheimer's disease. Here, CYP1A1 is linked to early-onset autosomal dominant Alzheimer disease.